We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia...
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on...
MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported...
MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and...
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi®...
MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its...
MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian...
MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a Pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of BIJUVA®...
This stock is almost a penny stock no longer, as shares moved close to the $5 threshold following the firm’s quarterly announcement. Leading pan-American (ex-US) specialty pharmaceutical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -1.71526586621 | 5.83 | 5.88 | 5.56 | 33986 | 5.74145532 | CS |
4 | 0.42 | 7.90960451977 | 5.31 | 5.95 | 5.23 | 58157 | 5.6651476 | CS |
12 | 0.35 | 6.50557620818 | 5.38 | 5.95 | 5.21 | 74090 | 5.47265309 | CS |
26 | 1.21 | 26.7699115044 | 4.52 | 5.95 | 4.42 | 69414 | 5.36769516 | CS |
52 | 0.95 | 19.8744769874 | 4.78 | 5.95 | 4.35 | 71195 | 5.03513607 | CS |
156 | 0.27 | 4.94505494505 | 5.46 | 6.2 | 4.28 | 162405 | 5.26086414 | CS |
260 | -1.55 | -21.2912087912 | 7.28 | 8.88 | 4.28 | 234160 | 6.04400089 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions